Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$8.28M+79.5%-$40.37M-6.2%-$38M+9.4%-$41.93M+90.2%-$426.08M
$2.2M-19.6%$2.74M+11.2%$2.46M-7.4%$2.66M-48.2%$5.13M+80.5%
$4.46M-53.5%$9.59M-12.7%$10.98M-7.7%$11.9M+29.3%$9.2M-42.6%
-$44.69M-134%-$19.07M-1.9%-$18.71M+36.3%-$29.38M+33.3%-$44.06M-43.7%
$3.04M+253%$861K$0-100%$550K-60.4%$1.39M-14.1%
$35.86M+37.8%$26.03M+37.7%$18.9M-25.2%$25.28M-44.1%$45.23M-22.3%
$1.44M$1.47M$1.96M+104%
-$7.4M-206%$6.96M+318%$1.66M+141%-$4.09M-231%$3.14M+114%
-$47.73M-140%-$19.93M-7.0%-$18.62M+37.8%-$29.93M+34.1%-$45.45M-40.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pacific Biosciences of California generate?
Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
What is Pacific Biosciences of California's free cash flow?
After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
Where does Pacific Biosciences of California's cash flow data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.